AbbVie Ready to Breakdown?

NYSE: ABBV | AbbVie Inc.  News, Ratings, and Charts

ABBV – A critical support level has formed in the chart of AbbVie (ABBV). If the stock price falls below this level, a breakdown is expected. Read more to learn how to take advantage of this trade.

A key support level has emerged in the chart of AbbVie Inc. (ABBV - Get Rating).  If the stock price falls below this level, a breakdown is expected.

ABBV is a drug company with leadership roles in therapeutic areas including immunology, hematologic oncology, neuroscience, aesthetics, eye care and women’s health. The company’s top drug, Humira, represents close to half of the company’s current profits.

The company outperformed fourth quarter estimates for earnings and sales. It has been successful in expanding labels for cancer drugs, Imbruvica and Venclexta and has a strong late-stage pipeline. ABBV’s acquisition of Allergan has diversified its revenue into new areas, providing it with additional long-term growth prospects.

ABBV had $8.47 billion in cash as of the end of the latest quarter, but its short-term debt was a little higher at $8.5 billion. Though the company is quite profitable with a return on equity of 34.8%.

While the stock is up over 60% in the past twelve months, it has been trending down over the past month. This has led to a Momentum Grade of D in our POWR Ratings system.

Take a look at the 1-year chart of ABBV below with added notations:

  Chart of ABBV provided by TradingView

ABBV has created a key level of support at the $102 (green) level over the past several months. The stock has made its way back down to that level again, and another bounce took place.

If the support level were to break, a breakdown is expected and lower prices will likely follow for ABBV. Therefore, a trader could enter a short position if the stock were to break $102.

Want to Discover More Great Trades?

I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don’t work at all.

That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter…the ones that lead to the most timely and profitable stock trades. Click below to get your copy now!

5 WINNING Stock Chart Patterns

Have a good trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach


ABBV shares were trading at $104.54 per share on Friday morning, up $0.66 (+0.64%). Year-to-date, ABBV has declined -1.29%, versus a 4.97% rise in the benchmark S&P 500 index during the same period.


About the Author: Christian Tharp


I am an expert stock market coach having helped over 4000 beginner and advanced traders & investors from around the world take control of their financial futures. I also write stock market related articles for the Adam Mesh Trading Group and Yolo Publishing. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ABBVGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Stocks in Unchartered Territory

The S&P 500 (SPY) is in unchartered territory given how it is flirting with the 200 day moving average. This makes the outlook uncertain. Steve Reitmeister tries to make sense of it all in this timely commentary.

Stock Market Alert: Disaster Averted?

Investors have been sitting on pins and needles as the S&P 500 (SPY) broke below the 200 day moving average. However it appears that disaster may have been averted with the rally this week. Steve Reitmeister shares the full story in the commentary to follow...

Bear Market Watch: Week 2

Why does Steve Reitmeister believe the S&P 500 (SPY) needs to be back above 5,747 by 3/31 or it spells trouble for investors? Read on below for the full answer...

Has the Next Bear Market Already Arrived?

The recent break below the 200 day moving average for the S&P 500 (SPY) has a lot of investors worried that the next bear market has already arrived. Investment expert Steve Reitmeister shares his timely views along with a trading plan to stay on the right side of the action.

How Low Will Stocks Go?

The S&P 500 (SPY) is testing the 200 day moving average with fears on tariffs and GDP that could push them even lower. Now is a good time to hear what 40 year investment veteran Steve Reitmeister says about the market outlook and odds of bear market.

Read More Stories

More AbbVie Inc. (ABBV) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ABBV News